Neonatal SEPSIS Clinical Trial
Official title:
Epidemiology of Neonatal Sepsis in Infants Admitted to Neonatal Intensive Care Unit in Assiut University Children Hospital
Neonatal sepsis is an important cause of morbidity and mortality in the pediatric age group . It is one of the leading causes of death in the first 28 days of life both in the developed and developing countries.
More than 40% of under-five deaths globally occur in the neonatal period, resulting in 3.1
million newborn death each year.
The majority of these deaths usually occur in low income countries . On the other hand, the
survivors of neonatal sepsis are vulnerable to short- and long term neurodevelopmental
morbidity .
Neonatal sepsis is a clinical syndrome characterized by signs and symptoms of infection with
or without accompanying bacteremia in the first month of life. It includes various systemic
infections of the newborn such as septicemia, meningitis, pneumonia, arthritis,
osteomyelitis, and urinary tract infections. Superficial infections like conjunctivitis and
oral thrush are usually not included under neonatal sepsis.
Diagnosis of sepsis in neonates is challenging due to nonspecific signs and symptoms. The
salient clinical features include systemic signs of infection such as fever, hypothermia,
tachycardia, failure to thrive, lethargy, irritability, restlessness In addition, laboratory
diagnosis until recently was time-consuming. This, therefore, necessitates the initiation of
empirical antibiotic therapy pending a definitive diagnosis .
Neonatal sepsis is caused by Gram-positive and Gram-negative bacteria and Candida. The
diversity of organisms causing sepsis varies from region to another and changes over time
even in the same place .
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05692128 -
Frequency and Severity of Thrombocytopenia in Neonatal Sepsis
|
||
Completed |
NCT00942084 -
A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo)
|
Phase 1 | |
Completed |
NCT06002295 -
A Comparative Analysis of 4% Chlorhexidine Versus Methylated Spirit as Prophylaxis of Omphalitis and Sepsis in Newborns
|
Phase 2 | |
Not yet recruiting |
NCT05114057 -
Use of NGAL for Fluid Dosing and CRRT Initiation in Pediatric and Neonatal AKI
|
N/A | |
Recruiting |
NCT04528251 -
Comparison of the Effectiveness of Two Different Antibiotic Regimens of the Treatment of Pregnant Women With Preterm Rupture of Membranes
|
||
Active, not recruiting |
NCT03871491 -
Azithromycin-Prevention in Labor Use Study (A-PLUS)
|
Phase 3 | |
Completed |
NCT03746743 -
Severity Index of Neonatal Septicemia Using Score for Neonatal Acute Physiology (SNAP) II
|
||
Completed |
NCT02386592 -
Prevention of Nosocomial Bacteremia Among Zambian Neonates
|
N/A | |
Not yet recruiting |
NCT06113653 -
Outcomes and Predictors of Mortality Among Preterm Infants With Neonatal Sepsis
|
||
Completed |
NCT03199547 -
Pre-delivery Administration of Azithromycin to Prevent Neonatal Sepsis & Death
|
Phase 3 | |
Completed |
NCT02147327 -
Effects of Cord Blood 25-hydroxy-vitamin D Level on Early Neonatal Morbidities
|
N/A | |
Completed |
NCT01005589 -
CD64 Measurement in Neonatal Infection and Necrotising Enterocolitis
|
N/A | |
Completed |
NCT00866567 -
Defects in Opsonophagocytosis in Premature Infants
|
N/A | |
Completed |
NCT02281890 -
Neurodevelopmental Outcomes After Suspected or Proven Sepsis: Secondary Analysis of INIS Trial Database
|
N/A | |
Suspended |
NCT05156333 -
Probiotics and GBS Colonization in Pregnancy
|
N/A | |
Recruiting |
NCT05127070 -
Evaluating the NeoTree in Malawi and Zimbabwe
|
||
Completed |
NCT03755635 -
Neonatal Sepsis at Neonatal Intensive Care Units in Ghana
|
N/A | |
Completed |
NCT03247920 -
Reduction of Intravenous Antibiotics In Neonates
|
Phase 4 | |
Completed |
NCT03295162 -
Effects of Melatonin as a Novel Antioxidant and Free Radicals Scavenger in Neonatal Sepsis
|
Phase 1/Phase 2 | |
Completed |
NCT02954926 -
Intravenous Immunoglobulin in Prevention of Preterm Neonatal Sepsis
|
Phase 3 |